Product Information
Name:GSK163929
Brand:Targetmol
Description:GSK163929 (compound 122) is an orally active CCR5 antagonist with anti-HIV properties and demonstrates low inhibitory potency against hEGR. Administered at a dosage of 2000 mg/kg/day (i.v., 7 d), it shows no adverse effects in rats, and at 250 mg/kg/day (i.v., 7 d), it is similarly non-toxic in dogs.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:696.25
Formula:C36H40ClF2N5O3S
Color/Form:Solid
Technical inquiry about: GSK163929
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.